[Treatment of heart failure with vasodilators].
D002216:Captopril / Q000627:therapeutic use; D006332:Cardiomegaly / Q000188:drug therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006334:Heart Function Tests; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D006830:Hydralazine; D002216:Captopril; D005996:Nitroglycerin; D011224:Prazosin; D010646:Phentolamine
Behandlung der Herzinsuffizienz mit Vasodilatantien.